Medical cannabis has been developing rapidly to a significant industry in Denmark. Since the launch of a four-year pilot period, several companies were established along the value chain from breeding, production, processing and development of medical products.
The production and export of medical cannabis will be governed by a permanent framework as of 2022. Development of the industry will continue to accelerate as exports have started. The first movers are scaling up while new entrants to the industry attempt to establish themselves in this dynamic industry. Building on a strong regulatory framework that encourages high standards and open competition, Denmark is establishing a leading position that draws on traditional strengths in biotechnology and applied research.
Partnerships across the ecosystem are emerging in areas like breeding, sustainable production methods, and clinical research, but more integration is needed across the entire ecosystem to meet the demands of the industry.
This is the theme of this year’s arrangement: Collaboration and partnerships.
The event will include live attendance as well as online option.